Naproxen Hermes

Naproxen, the active ingredient in Naproxen Hermes, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral tablet for oral use. It treats pain, inflammation and arthritic conditions in adult patients.

GNH USA supplies Naproxen Hermes as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Naproxen is an NSAID that reduces pain and inflammation across several musculoskeletal conditions. - Pain: Provides analgesic relief for acute and chronic pain states. - Inflammation: Decreases inflammatory response in soft‑tissue injuries. - Arthritis: Alleviates joint pain and swelling associated with osteoarthritis and rheumatoid arthritis. - Musculoskeletal pain: Improves comfort in back, neck and limb disorders.

Adverse reactions may range from mild to severe and should be monitored during therapy.

Common Side Effects: - Gastrointestinal upset: nausea, dyspepsia or abdominal discomfort. - Headache: mild to moderate intensity. - Dizziness or vertigo. - Rash or mild skin irritation. - Elevated blood pressure.

Serious or Rare Side Effects: - Gastrointestinal bleeding or ulceration. - Renal impairment or acute kidney injury. - Cardiovascular events such as myocardial infarction or stroke. - Severe skin reactions (e.g., Stevens‑Johnson syndrome). - Hepatic dysfunction or elevated liver enzymes. - Anaphylaxis or severe hypersensitivity.

Before initiating therapy, clinicians should evaluate patient‑specific risk factors and monitor for complications. - Assess gastrointestinal risk: consider ulcer prophylaxis in high‑risk patients. - Evaluate renal function: avoid in severe renal impairment. - Monitor cardiovascular status: use lowest effective dose in patients with heart disease. - Avoid in known hypersensitivity to naproxen or other NSAIDs. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Naproxen can alter the pharmacodynamics or pharmacokinetics of several co‑administered medicines.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Other NSAIDs or aspirin: additive gastrointestinal toxicity. - Selective serotonin reuptake inhibitors (SSRIs): heightened hemorrhagic potential. - Lithium: possible increase in lithium serum levels. - Methotrexate: reduced clearance leading to toxicity.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may diminish antihypertensive effect. - Diuretics: risk of renal function decline. - Corticosteroids: synergistic ulcerogenic effect. - Cyclosporine: increased nephrotoxicity. - Beta‑blockers: potential reduction in blood pressure control.